Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1
Pan Chuan-fang(Shanghai University of Traditional Chinese Medicine), Ke‐Ping Shen(Shanghai University of Traditional Chinese Medicine)
Cited by 20
Related Papers
Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials
|Oncology Research and Treatment|2019|36